We are live on ! Find out more
FG

Fairman Group Portfolio holdings

AUM $127M Turnover 8.16%
1-Year Est. Return 6.28%
This Fund
S&P 500
This Quarter Est. Return
+5.15%
1 Year Est. Return
+6.28%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$1.27M
Cap. Flow
-$2.93M
Cap. Flow %
-2.77%
Top 10 Hldgs %
73.91%
Holding
410
New
15
Increased
51
Reduced
47
Closed
11
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.3 years
Top 20 Avg Time Held
0.2 years

Top Sells

Rank Stock Value
1
ESNT icon
Essent Group
ESNT
+$813K
2
ACCD icon
Accolade Inc
ACCD
+$455K
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$401K
4
NVDA icon
NVIDIA
NVDA
+$286K
5
VEEV icon
Veeva Systems
VEEV
+$267K

Sector Composition

Rank Sector Weight
1 Miscellaneous 37.44%
2 Technology 30.29%
3 Industrials 12.44%
4 Financials 12.26%
5 Healthcare 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HLN icon
376
Haleon
HLN
$44.2B
$215 ﹤0.01%
25
– –
2023 Q4
1 quarter
KW icon
377
DELISTED
Kennedy-Wilson Holdings
KW
$212 ﹤0.01%
24
– –
2023 Q4
1 quarter
WBD icon
378
DELISTED
Warner Bros
WBD
$210 ﹤0.01%
24
+6
+33% +$58
2023 Q4
1 quarter
MAT icon
379
Mattel
MAT
$4.91B
$198 ﹤0.01%
10
– –
2023 Q4
1 quarter
GEHC icon
380
GE HealthCare
GEHC
$31.8B
$182 ﹤0.01%
2
– –
2023 Q4
1 quarter
CGNX icon
381
Cognex
CGNX
$9.25B
$170 ﹤0.01%
4
– –
2023 Q4
1 quarter
REFR icon
382
Research Frontiers
REFR
$23.1M
$163 ﹤0.01%
125
– –
2023 Q4
1 quarter
NEUE icon
383
DELISTED
NeueHealth
NEUE
$163 ﹤0.01%
25
– –
2023 Q4
1 quarter
VTGN icon
384
VistaGen Therapeutics
VTGN
$9.08M
$153 ﹤0.01%
29
– –
2023 Q4
1 quarter
FULT icon
385
Fulton Financial
FULT
$4.29B
$145 ﹤0.01%
+9
New +$141
2024 Q1
0 quarters
IMMR icon
386
Immersion
IMMR
$235M
$142 ﹤0.01%
19
– –
2023 Q4
1 quarter
JXN icon
387
Jackson Financial
JXN
$8.97B
$132 ﹤0.01%
2
– –
2023 Q4
1 quarter
ENOV icon
388
Enovis
ENOV
$1.13B
$125 ﹤0.01%
2
– –
2023 Q4
1 quarter
CYRX icon
389
CryoPort
CYRX
$854M
$124 ﹤0.01%
7
– –
2023 Q4
1 quarter
FWONA icon
390
Liberty Media Corporation Series A Common Stock
FWONA
$20.9B
$117 ﹤0.01%
2
– –
2023 Q4
1 quarter
CVGW icon
391
DELISTED
Calavo Growers
CVGW
$112 ﹤0.01%
4
– –
2023 Q4
1 quarter
URBN icon
392
Urban Outfitters
URBN
$7.65B
$87 ﹤0.01%
2
– –
2023 Q4
1 quarter
SEIC icon
393
SEI Investments
SEIC
$12.6B
$61 ﹤0.01%
1
– –
2023 Q4
1 quarter
CIEN icon
394
Ciena
CIEN
$48.3B
$49 ﹤0.01%
+1
New +$53
2024 Q1
0 quarters
REZI icon
395
Resideo Technologies
REZI
$2.55B
$45 ﹤0.01%
2
– –
2023 Q4
1 quarter
KLG icon
396
DELISTED
WK Kellogg Co
KLG
$38 ﹤0.01%
2
– –
2023 Q4
1 quarter
ASIX icon
397
AdvanSix
ASIX
$443M
$29 ﹤0.01%
1
– –
2023 Q4
1 quarter
GTX icon
398
Garrett Motion
GTX
$4.56B
$20 ﹤0.01%
2
– –
2023 Q4
1 quarter
ONL icon
399
Orion Office REIT
ONL
$119M
$4 ﹤0.01%
1
– –
2023 Q4
1 quarter
AWK icon
400
American Water Works
AWK
$26.8B
– –
-320
Closed -$42.2K –

Similar funds

Fairman Group's Q1 2024 Portfolio in Review

As of Q1 2024, Fairman Group held 410 positions worth $106M, up 1.2% from $105M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Fairman Group's Q1 2024 filing shows 15 new, 51 increased, 47 reduced and 11 closed positions. Its largest new stake was Quaker Houghton: 1,733 shares worth $356K. The largest sale was Essent Group, an estimated $813K.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.

  • Fairman Group's largest Q1 2024 buy was Quaker Houghton: 1,733 shares worth $356K.
  • Fairman Group added most to iShares Core S&P Mid-Cap ETF in Q1 2024, an estimated $467K increase.
  • Fairman Group's biggest Q1 2024 reduction was Essent Group, cutting an estimated $813K.
  • Fairman Group fully exited Intuit in Q1 2024, selling an estimated $100K.
  • Fairman Group's ten largest holdings make up 74% of its $106M portfolio in Q1 2024.
  • Fairman Group opened 15 new positions and closed 11 in Q1 2024.
  • Fairman Group's portfolio value rose 1.2% quarter-over-quarter to $106M.

Based on Fairman Group's 13F filing for Q1 2024, filed 30 Apr 2024.